Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

The treatment was effective for lupus nephritis with manageable side effects.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The extract from the plant Adiantum capillus-veneris might be used to treat COVID-19.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

JAK inhibitors are effective for long-term management of alopecia areata.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

PTH-CBD helps reduce hair loss in mice by stimulating hair growth directly.